Navigation Links
Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
Date:2/22/2010

s an enormous unmet need to help reduce the individual and economic burden of obesity," said Christian Weyer, M.D., vice president, medical development at Amylin Pharmaceuticals. "Through our global co-development and commercialization agreement with Takeda, we are committed to developing innovative therapies to help the millions of people who need better solutions to manage obesity. Today's announcement is an important step forward in helping us make good on that commitment."

"We are pleased with the results of the Phase 2 extension study for the pramlintide/metreleptin combination therapy," said Nancy Joseph-Ridge, M.D., general manager of Takeda's Pharmaceutical Development Division. "This potential new therapy continues to build on our commitment to the management of obesity."

In this extension of a 28-week Phase 2 dose-ranging study, patients who continued treatment with pramlintide/metreleptin for a total of 52 weeks demonstrated sustained weight loss, whereas those continuing on placebo regained almost all of their weight. Consistent with results at 28 weeks, the most robust efficacy was seen in patients with a body mass index (BMI) less than 35 kg/m2.

The combination therapy appeared to be generally well tolerated through 52 weeks, with nausea and injection site adve
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amylin Pharmaceuticals to Webcast Year-End Financial Results
2. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
3. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
4. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
7. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
8. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
9. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
10. Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate)
11. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... BUENA, N.J. , June 30, 2015  IGI ... Jersey based specialty generic pharmaceutical company, today ... application (ANDA) to the U.S. Food and Drug Administration ... of ANDA submissions now pending at the FDA to ... CEO of the Company, commented, "We believe our current ...
(Date:6/30/2015)... Millar, Inc. , a leader in catheter-based and wireless ... Craig Thummel , President/CEO and member of the ... the Company. The Company also announced its leadership succession ... Management team as his successors. The Board of Directors ... Sales and Marketing, as President, and also a member ...
(Date:6/30/2015)... June 30, 2015 A new analysis ... exposure to high-priced Hepatitis C medications could range ... percent of Californians infected with Hepatitis C receive treatment through ... of new Hepatitis C treatments on public programs, comes at ... price tags for drugs like Gilead Sciences, Harvoni and Sovaldi. ...
Breaking Medicine Technology:IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015 2Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 3New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 4
... Reportlinker.com announces that a new market research ... Commercial Insight: Antihormonal Cancer Therapies ... sales erosion http://www.reportlinker.com/p0255121/Commercial-Insight-Antihormonal-Cancer-Therapies---Leading-brands-strive-to-minimize-generic-sales-erosion.html ... are a class of drugs used predominantly ...
... Ind., Nov. 8, 2010 EXTENSION, INC . announced ... it will make available for general release to the healthcare ... existing offerings use Cisco IP devices and smartphones as end ... the smartphone devices will not only serve as communication end ...
Cached Medicine Technology:Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 2Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 3Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 4Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 5Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 6Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 7Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 8Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion 9EXTENSION, INC. to Launch Apple iPhone Application for Use in Clinical Workflows 2EXTENSION, INC. to Launch Apple iPhone Application for Use in Clinical Workflows 3
(Date:7/1/2015)... PA (PRWEB) , ... July 01, 2015 , ... Who ... meaning and purpose in life with a healthy balance between work and life, and ... this in her new book, Positive Health: Flourishing Lives, Wellbeing in Doctors. , With ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Recovery Workforce ... PAPRS, welcomed Scott Stossel, editor of The Atlantic, as a keynote on June 2nd ... anxiety, and how telling his personal story added power and reach to the essential ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Thule Atmos X4 offers ... tested to ensure it lived up to Thule’s rigorous standards. Due to its Bi-ComponentArmor ... quality Thule owners have come to expect. , The Thule Atmos X4 ...
(Date:7/1/2015)... ... July 01, 2015 , ... RF ... solutions, has partnered with WIU Crossroads School in safeguarding its staff and students ... (Alternative Education for Disruptive Youth) environment of Crossroads School heightens the potential for ...
(Date:7/1/2015)... Vegas, NV (PRWEB) , ... July 01, 2015 ... ... will be showcasing the newly launched Patient Self-Management (PSM) Solutions at the Society ... model that has been in use for over 10 years, can reduce overall ...
Breaking Medicine News(10 mins):Health News:Medical Doctor Explains The Healthy Effects of a Positive Outlook in New Book 2Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 2Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 4Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 5Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 2Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 3Health News:APhA Foundation to Showcase Newly Introduced Patient Self-Management Solutions at the Society for Human Resource Management (SHRM) Annual Conference and Exposition 2
... repeatedly advised and now reinforced by a study, eating your ... things. Yet another benefit of eating// vegetables like spinach ... of developing stomach cancer. ,The study was conducted ... Medicine of the Karolinska Institute in Sweden. The team wanted ...
... of studies offers good news and bad news for women ... ,The good news is that screening mammography does ... screening mammograms are 15 percent less likely to die of ... ,The bad news is that women in a screened ...
... effect on aging markers such as muscle strength, peak ... elderly men and// women, according to Mayo Clinic researchers. ... Oct. 19 issue of the New England Journal of ... belief that dehydroepiandrosterone (DHEA), sold extensively as an antiaging ...
... at the San Francisco VA Medical Center has shown that ... medications for elders. //Nearly 40 percent of patients who took ... medication along with other medications, according to lead author Michael ... not just a question of, 'are you taking too much ...
... Medicine in St. Louis have helped usher in a new ... devices — rather than a scalpel — they've greatly ... ,"Because of the devices, the procedure — called the ... anyone was doing to one that 80 to 90 percent ...
... is one of the major causes of ailments and early death ... for the disease, in fact, starts at an early age. // ... study to find out the risk factors for early blood vessel ... ,Dr Julian Ayer from the Heart Research Institute is ...
Cached Medicine News:Health News:Mammograms Reduce Breast Cancer Deaths, But Increase Overdiagnosis 2Health News:Mammograms Reduce Breast Cancer Deaths, But Increase Overdiagnosis 3Health News:Mammograms Reduce Breast Cancer Deaths, But Increase Overdiagnosis 4Health News:Popular Antiaging Supplement Has No Beneficial Effects 2Health News:Doctors must exercise caution while prescribing medicines to elders 2Health News:High-Energy Clamp Simplifies Heart Surgery for Atrial Fibrillation 2Health News:High-Energy Clamp Simplifies Heart Surgery for Atrial Fibrillation 3Health News:Risk Factors in childhood for early blood vessel damage 2
For the qualitative detection of IgG/IgM antibodies to B. burgdorferi...
... surgical-quality loupes available at manufacturer-direct ... innovative optical design, combining superior quality ... with maximum comfort, SheerVision loupes are ... worldwide. Make both a professional and ...
... surgical-quality loupes available at manufacturer-direct ... innovative optical design, combining superior quality ... with maximum comfort, SheerVision loupes are ... worldwide. Make both a professional and ...
... the first manufacturer to offer through-the-lens ... wearer. These next generation loupes feature ... ultra-lightweight design, and are multi-coated lens ... With SheerVision's proprietary SureFit system - ...
Medicine Products: